Agios Pharmaceuticals Highlights Extensive Cancer Metabolism Research at American Association for Cancer Research

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Agios Pharmaceuticals, the first biopharmaceutical company focused on discovering and developing novel cancer metabolism drugs, highlights the breadth and depth of research in the field of cancer metabolism presented at the 100th American Association for Cancer Research (AACR) annual meeting in Denver, Colorado last week.

Back to news